WallStreetZenWallStreetZen

NASDAQ: FNCH
Finch Therapeutics Group Inc Stock

$5.88-0.20 (-3.29%)
Updated Sep 22, 2023
FNCH Price
$5.88
Fair Value Price
N/A
Market Cap
$9.44M
52 Week Low
$5.48
52 Week High
$60.00
P/E
-0.07x
P/B
0.34x
P/S
54.11x
PEG
N/A
Dividend Yield
N/A
Revenue
$253.00k
Earnings
-$138.27M
Gross Margin
100%
Operating Margin
-56,473.52%
Profit Margin
-54,651.4%
Debt to Equity
1.4
Operating Cash Flow
-$56M
Beta
0.93
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

FNCH Overview

Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered drugs in the U.S. The company collaborates and has license agreements with Takeda Pharmaceutical Company Ltd, Skysong Innovations LLC, and the University of Minnesota. The company was incorporated in 2014 and is based in Somerville, MA.

Zen Score

Industry Average (25)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how FNCH scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

FNCH is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
FNCH is good value based on its book value relative to its share price (0.34x), compared to the US Biotechnology industry average (5.11x)
P/B vs Industry Valuation
FNCH is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more FNCH due diligence checks available for Premium users.

Be the first to know about important FNCH news, forecast changes, insider trades & much more!

FNCH News

Valuation

FNCH price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.07x
Industry
12.89x
Market
14.52x

FNCH price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.34x
Industry
5.11x
FNCH is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

FNCH's financial health

Profit margin

Revenue
$0.0
Net Income
-$7.0M
Profit Margin
0%
FNCH's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
FNCH's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$66.9M
Liabilities
$39.0M
Debt to equity
1.4
FNCH's short-term assets ($36.50M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
FNCH's short-term assets ($36.50M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
FNCH's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$9.2M
Investing
$1.3M
Financing
$4.0k
FNCH's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

FNCH vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
FNCH$9.44M-3.27%-0.07x0.34x
BNOX$9.43M+7.54%-0.01x0.29x
TMBR$9.41M-1.93%-0.96x-3.59x
ITRM$9.39M-0.41%-0.16x1.32x
CANF$9.30M-6.30%-0.84x1.35x

Finch Therapeutics Group Stock FAQ

What is Finch Therapeutics Group's quote symbol?

(NASDAQ: FNCH) Finch Therapeutics Group trades on the NASDAQ under the ticker symbol FNCH. Finch Therapeutics Group stock quotes can also be displayed as NASDAQ: FNCH.

If you're new to stock investing, here's how to buy Finch Therapeutics Group stock.

What is the 52 week high and low for Finch Therapeutics Group (NASDAQ: FNCH)?

(NASDAQ: FNCH) Finch Therapeutics Group's 52-week high was $60.00, and its 52-week low was $5.48. It is currently -90.2% from its 52-week high and 7.32% from its 52-week low.

How much is Finch Therapeutics Group stock worth today?

(NASDAQ: FNCH) Finch Therapeutics Group currently has 1,604,761 outstanding shares. With Finch Therapeutics Group stock trading at $5.88 per share, the total value of Finch Therapeutics Group stock (market capitalization) is $9.44M.

Finch Therapeutics Group stock was originally listed at a price of $639.61 in Mar 19, 2021. If you had invested in Finch Therapeutics Group stock at $639.61, your return over the last 2 years would have been -99.08%, for an annualized return of -90.41% (not including any dividends or dividend reinvestments).

How much is Finch Therapeutics Group's stock price per share?

(NASDAQ: FNCH) Finch Therapeutics Group stock price per share is $5.88 today (as of Sep 22, 2023).

What is Finch Therapeutics Group's Market Cap?

(NASDAQ: FNCH) Finch Therapeutics Group's market cap is $9.44M, as of Sep 24, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Finch Therapeutics Group's market cap is calculated by multiplying FNCH's current stock price of $5.88 by FNCH's total outstanding shares of 1,604,761.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.